On Thursday the Swiss medicines regulator Swissmedic released data on side effects of Covid-19 vaccines as of March 8. While women were clearly more affected by the jabs, overall the majority of reports (70%) were not serious. Of the minority that were classified as serious the most common adverse reactions were fever (24), shortness of breath (18), Covid-19 disease (14), vomiting (11), hypersensitivity (11), anaphylactic reactions (8), headache/migraine (11) and reactivation of shingles (8).
A total of 21 people died at various intervals after receiving the vaccine. However, their average age was 85 and the majority had pre-existing conditions.
“As far as is known at present, death was caused by conditions such as infections, cardiovascular events or diseases of the lungs and airways that occurred independently of the vaccination. Despite a chronological correlation, there is no concrete evidence to suggest that the vaccination was the cause of death,” said an official statement.
There was not much of a difference between the two vaccines administered in the country when it came to side effects. Pfizer/BioNTech’s Comirnaty accounted for 343 adverse reaction reports while Moderna’s vaccine was responsible for 251. The AstraZeneca vaccine has not yet been approved by Swissmedic.
Overall, the medicines regulator said the data on adverse reactions was within the norm and no new worrying trends were identified.
“The reports corroborate the side effects profile identified during the authorisation studies and described in the medicinal product information. There is no evidence to date of any new safety signals, so the positive ratio of benefits to risks of the two authorised vaccines is still the same,” said the authorities.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.